🇺🇸 FDA
Patent

US 10189784

N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase

granted A61PA61P3/00

Quick answer

US patent 10189784 (N-(5-((aryl or heteroaryl)methyloxy)pentyl)-substituted iminosugars as inhibitors of glucosylceramide synthase) held by ACADEMISCH MEDISCH CENTRUM expires Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ACADEMISCH MEDISCH CENTRUM
Grant date
Tue Jan 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P3/00